190 related articles for article (PubMed ID: 22569231)
21. Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery.
Porta F; Lamers GE; Morrhayim J; Chatzopoulou A; Schaaf M; den Dulk H; Backendorf C; Zink JI; Kros A
Adv Healthc Mater; 2013 Feb; 2(2):281-6. PubMed ID: 23184490
[No Abstract] [Full Text] [Related]
22. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
Paula AJ; Araujo Júnior RT; Martinez DS; Paredes-Gamero EJ; Nader HB; Durán N; Justo GZ; Alves OL
ACS Appl Mater Interfaces; 2013 Sep; 5(17):8387-93. PubMed ID: 23841723
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764
[TBL] [Abstract][Full Text] [Related]
24. Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer.
Teng IT; Chang YJ; Wang LS; Lu HY; Wu LC; Yang CM; Chiu CC; Yang CH; Hsu SL; Ho JA
Biomaterials; 2013 Oct; 34(30):7462-70. PubMed ID: 23810081
[TBL] [Abstract][Full Text] [Related]
25. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
26. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
27. Fabrication of Mesoporous Silica Nanoparticle with Well-Defined Multicompartment Structure as Efficient Drug Carrier for Cancer Therapy in Vitro and in Vivo.
Wang A; Yang Y; Qi Y; Qi W; Fei J; Ma H; Zhao J; Cui W; Li J
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8900-7. PubMed ID: 26998895
[TBL] [Abstract][Full Text] [Related]
28. A general strategy for dual-triggered combined tumor therapy based on template semi-graphitized mesoporous silica nanoparticles.
Wang Y; Wang K; Yan X; Huang R
Adv Healthc Mater; 2014 Apr; 3(4):485-9. PubMed ID: 23997032
[TBL] [Abstract][Full Text] [Related]
29. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process.
Lin Q; Huang Q; Li C; Bao C; Liu Z; Li F; Zhu L
J Am Chem Soc; 2010 Aug; 132(31):10645-7. PubMed ID: 20681684
[TBL] [Abstract][Full Text] [Related]
30. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier.
Tang Q; Cao B; Cheng G
Chem Commun (Camb); 2014 Feb; 50(11):1323-5. PubMed ID: 24343195
[TBL] [Abstract][Full Text] [Related]
31. Accelerated Achilles tendon healing by PDGF gene delivery with mesoporous silica nanoparticles.
Suwalski A; Dabboue H; Delalande A; Bensamoun SF; Canon F; Midoux P; Saillant G; Klatzmann D; Salvetat JP; Pichon C
Biomaterials; 2010 Jul; 31(19):5237-45. PubMed ID: 20334910
[TBL] [Abstract][Full Text] [Related]
32. Shape design of high drug payload nanoparticles for more effective cancer therapy.
Li W; Zhang X; Hao X; Jie J; Tian B; Zhang X
Chem Commun (Camb); 2013 Dec; 49(93):10989-91. PubMed ID: 24136236
[TBL] [Abstract][Full Text] [Related]
33. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation.
Botella P; Abasolo I; Fernández Y; Muniesa C; Miranda S; Quesada M; Ruiz J; Schwartz S; Corma A
J Control Release; 2011 Dec; 156(2):246-57. PubMed ID: 21756949
[TBL] [Abstract][Full Text] [Related]
34. Peptide p160-coated silica nanoparticles applied in photodynamic therapy.
Yang Y; Wang A; Jia Y; Brezesinski G; Dai L; Zhao J; Li J
Chem Asian J; 2014 Aug; 9(8):2126-31. PubMed ID: 24895152
[TBL] [Abstract][Full Text] [Related]
35. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
[TBL] [Abstract][Full Text] [Related]
36. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
37. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
Liu Q; Zhang J; Xia W; Gu H
Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
[TBL] [Abstract][Full Text] [Related]
38. Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs.
Gu J; Su S; Li Y; He Q; Shi J
Chem Commun (Camb); 2011 Feb; 47(7):2101-3. PubMed ID: 21183990
[TBL] [Abstract][Full Text] [Related]
39. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
40. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells.
Fang JY; Hung CF; Hua SC; Hwang TL
Ultrasonics; 2009 Jan; 49(1):39-46. PubMed ID: 18554679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
